Cardiovascular disease and chimeric antigen receptor cellular therapy

Chimeric antigen receptor T-cell (CAR T) therapy is a revolutionary personalized therapy that has significantly impacted the treatment of patients with hematologic malignancies refractory to other therapies. Cytokine release syndrome (CRS) is a major side effect of CAR T therapy that can occur in 70...

Full description

Bibliographic Details
Main Authors: Anjali Rao, Andrew Stewart, Mahmoud Eljalby, Praveen Ramakrishnan, Larry D. Anderson, Farrukh T. Awan, Alvin Chandra, Srilakshmi Vallabhaneni, Kathleen Zhang, Vlad G. Zaha
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.932347/full

Similar Items